Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Saftey and Efficacy of the Viatar™ Oncopheresis System in Removing Circulating Tumor Cells From Whole Blood

NCT03058809 is registered in ClinicalTrials.gov with Viatar LLC as lead sponsor.

NCT NCT03058809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03058809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Saftey and Efficacy of the Viatar™ Oncopheresis System in Removing Circulating Tumor Cells From Whole Blood
Lead sponsor
Viatar LLC
Phase
Phase 1/2
Overall status
Unknown status
Start date
September 30, 2018
Completion date
May 31, 2019
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic cancer